mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.37 |
8e-20 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.42 |
5e-16 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.34 |
1e-15 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
1e-11 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
1e-06 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-06 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
6e-06 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-05 |